An oestrogen membrane receptor participates in estradiol actions for the prevention of amyloid-β peptide1-40-induced toxicity in septal-derived cholinergic SN56 cells

Journal of Neurochemistry

Volumn 85, Issue 5, 2003, Pages 1180-1189

  Marin, Raquel ^a   Guerra, Borja ^a   Morales, Araceli ^a   Díaz, Mario ^a   Alonso, Rafael ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

amyloid; Neuroprotection; Oestrogen; Oestrogen receptor; SN56 cell line

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; BOVINE SERUM ALBUMIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; FULVESTRANT; HORSERADISH PEROXIDASE; MC 20 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DEATH; CELL MEMBRANE; CELL STRAIN; CHOLINERGIC NERVE CELL; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; LIGAND BINDING; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; TOXICITY; WESTERN BLOTTING;

ACETYLCHOLINE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; BINDING, COMPETITIVE; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; ESTRADIOL; ESTROGEN ANTAGONISTS; MICE; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RECEPTORS, CELL SURFACE; RECEPTORS, ESTROGEN; SEPTUM OF BRAIN;

ANIMALIA; ARMORACIA RUSTICANA; BOVINAE;

EID: 0038579793     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01767.x     Document Type: Article

References (48)

1. Bergmeyer H. G. (1974) Methods of Enzymatic Analysis. Verlag Chemie, Academic Press, San Diego.
2. Black L. and Berenbaum M. C. (1964) Factors affecting the dye exclusion test for cell viability. Exp. Cell Res. 35, 9-13.
3. Blaustein J. D. (1992) Cytoplasmic estrogen receptors in rat brain: immunocytochemical evidence using three antibodies with distinct epitopes. Endocrinology 31, 281-290.
4. Chaney L. K. and Jacobson B. S. (1983) Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. J. Biol. Chem. 258, 10 062-10 072.
5. Clarke H. C., Norfleet A. M., Clarke M. S. F., Watson C. S., Cunningham K. A. and Thomas M. L. (2000) Perimembrane localization of the estrogen receptor α protein in neuronal processes of cultured hippocampal neurons. Neuroendocrinology 71, 34-42.
6. Coleman K. M. and Smith C. L. (2001) Intracellular signalling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front. Biosci. 6, d1379-d1391.
7. +-ATPase in the gilthead seabream (Sparus auratus L.). Evidence for a tissue-specific heterogeneity. Comp. Biochem. Physiol. 121B, 65-76.
8. Falkenstein E., Tillmann H. C., Christ M., Feuring M. and Wehling M. (2000) Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol. Rev. 52, 513-556.
9. Fitzpatrick J. L., Mize A. L., Wade C. B., Harris J. A., Shapiro R. A. and Dorsa D. M. (2002) Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J. Neurochem. 82, 674-682.
10. Garcia-Segura L. M., Azcoitia I. and DonCarlos L. L. (2001) Neuroprotection by estradiol. Prog. Neurobiol. 63, 29-60.
11. Gollapudi L. and Oblinger M. M. (1999) Stable transfection of PC12 cells with estrogen receptor (ERα): Protective effects of estrogen on cell survival after serum deprivation. J. Neurosci. Res. 56, 99-108.
12. Goodman Y., Bruce A. J., Cheng B. and Mattson M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
13. Green P. S. and Simpkins J. W. (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Devl Neurosci. 18, 347-358.
14. Green P. S., Gridley K. E. and Simpkins J. W. (1996) Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218, 165-168.
15. Green P. S., Perez E. J., Calloway T. and Simpkins J. W. (2000) Estradiol attenuation of beta-amyloid-induced toxicity: a comparison 0. J. Neurocytol. 29, 419-423.
16. Greenfield J. P., Leung L. W., Cai D., Kaasik K., Gross R. S., Rodriguez-Boulan E., Greengard P. and Xu H. (2002) Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J. Biol. Chem. 277, 12 128-12 136.
17. Hajek R. A., Robertson A. D., Van Johnston D. A. N. T., Tcholakian R. K., Wagner L. A., Conti C. J., Meistrich M. L., Contreras N., Edwards C. L. and Jones L. A. (1997) During development, 17α-estradiol is a potent estrogen and carcinogen. Environ. Health Perspect. (Suppl. 3) 105, 577-581.
18. Henderson V. W., Paganini-Hill A., Miller B. L., Elble R. J., Reyes P. F., Shoupe D., McCleary C. A., Klein R. A., Hake A. M. and Farlow M. R. (2000) Estrogen for Alzheimer's disease in women: randomised double-blind, placebo-controlled trial. Neurology 54, 295-301.
19. Kim H., Bang O. Y., Jun M. W., Ha S. D., Hong H. S., Huh K., Kim S. U. and Mook-Jung I. (2001) Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci. Lett. 302, 58-62.
20. MacGregor J. I. and Jordan V. C. (1998) Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50, 151-196.
21. Marin R., Guerra B. and Alonso R. (2001a) The amount of estrogen receptor α increases after heat shock in a cholinergic cell line from the basal forebrain. Neuroscience 107, 447-454.
22. Marin R., Guerra B. and Alonso R. (2001b) Estradiol prevents β-amyloid 1-40 induced toxicity in murine septal cells: evidence that intracellular estrogen receptors mediate this neuroprotective effect. Rev. Neurol. 33, 891 (P301).
23. Martinez-Morales J. R., Lopez-Coviella I., Hernandez-Jimenez J. G., Bello A. R., Hernandez G., Blusztajn J. K. and Alonso R. (2001) Sex steroids modulate LHRH secretion in a cholinergic cell line from the basal forebrain. Neuroscience 103, 1027-1033.
24. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nol E. and Auricchio F. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15, 1292-1300.
25. Milner T. A., McEwen B. S., Hayashi S., Li C. J., Reagan P. and Alves S. E. (2001) Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J. Comp. Neurol. 429, 355-371.
26. Mook-Jung I., Joo I., Sohn S., Kwon H. J., Huh K. and Jung M. W. (1997) Estrogen blocks neurotoxic effects of β-amyloid (1-42) and induces neurite extension on B103 cells. Neurosci. Lett. 235, 101-104.
27. Morey A. K., Pedram A., Razandi M., Prins B. A., Hu R.-H., Biesiada E. and Levin E. R. (1997) Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 138, 3330-3339.
28. Nadal A., Rovira J. M., Laribi Q., Leon-Quinto T., Andreu E., Ripoll C. and Soria B. (1998) Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J. 12, 1341-1348.
29. Nadal A., Ropero A. B., Maillet M., Fuentes E. and Soria B. (2000) Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β. Proc. Natl Acad. Sci. USA 97, 11 603-11 608.
30. Nadal A., Díaz M. and Valverde M. A. (2001) The estrogen trinity: Membrane, cytosolic, and nuclear effects. News Physiol. Sci. 16, 251-255.
31. Norfleet A. M., Thomas M. L., Gametchu B. and Watson C. S. (1999) Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140, 3805-3814.
32. Norfleet A. M., Clarke C. H., Gametchu B. and Watson C. S. (2000) Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J. 14, 157-165.
33. Pappas T. C., Gametchu B. and Watson C. S. (1995) Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 9, 404-410.
34. Petanceska S. S., Nagy V., Frail D. and Gandy S. (2000) Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology 54, 2212-2217.
35. Pietras R. J., Nemere I. and Szego C. M. (2001) Steroid hormone receptors in target cell membranes. Endocrine 14, 417-427.
36. Powell C. E., Watson C. S. and Gametchu B. (1999) Immunoaffinity isolation of native membrane glucocorticoid receptor from S49++ lymphoma cells: biochemical characterization and interaction with Hsp 70 and Hsp 90. Endocrine 10, 271-280.
37. Powell Ch, Soto A. M. and Sonnenschein C. (2001) Identification and characterization of membrane estrogen receptor from MCF7 estrogen-target cells. J. Steroid Biochem. Mol. Biol. 77, 97-108.
38. Razandi M., Pedram A., Greene G. L. and Levin E. R. (1999) Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13, 307-319.
39. Russell K. S., Haynes M. P., Sinha D., Clerisme E. and Bender J. R. (2000) Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signalling. Proc. Natl Acad. Sci. USA 97, 5930-5035.
40. Schmidt R., Pautrat G., Michel S., Cavey M. T., Gazith J., Dalbiez C. and Reichert U. (1985) High-Yield purification of plasma membranes from transformed human keratinocytes in culture. J. Invest. Dermatol. 85, 50-53.
41. Singer C. A., Figueroa-Masot X. A., Batchelor R. H. and Dorsa D. M. (1999) The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19, 2455-2463.
42. Tang M. X., Jacobs D., Stem Y., Marder K., Schofield P., Gurland B., Andrews H. and Mayeux R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
43. Toran-Allerand C. D., Guan X., MacLusky N. J., Horvath T. L., Diano S., Singh M., Connolly E. S., Nethrapalli I. S. and Tinnikov A. A. (2002) ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22, 8391-8401.
44. Truss M. and Beato M. (1993) Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 14, 459-479.
45. Watson C. S. and Gametchu B. (1999) Membrane-initiated steroid actions and the proteins that mediate them. Proc. Soc. Exp. Biol. Med. 220, 9-19.
46. Watters J. J., Campbell J. S., Cunningham M. J., Krebs E. G. and Dorsa D. M. (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138, 4030-4033.
47. Xu H., Gouras G. K., Greenfield J. P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J. N., Seeger M., Relkin N. R., Liao F., Checler F., Buxbaum J. D., Chait B. T., Thinakaran G., Sisodia S. S., Wang R., Greengard P. and Gandy S. (1998) Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4, 447-451.
48. Zheng H., Xu H., Uljon S. N., Gross R., Hardy K., Gaynor J., Lafrancois J., Simpkins J., Refolo L. M., Petanceska S., Wang R. and Duff K. (2002) Modulation of A (beta) peptides by estrogen in mouse models. J. Neurochem. 80, 191-196.